Benjamin Looker, the Chief Legal Officer of $ESPR, sold 5,708 shares of the company on 03-17-2026 for an estimated $15,428. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.8% of their shares of this class of stock. Following this trade, they now own 679,348 shares of this class of $ESPR stock.
$ESPR Insider Trading Activity
$ESPR insiders have traded $ESPR stock on the open market 11 times in the past 6 months. Of those trades, 0 have been purchases and 11 have been sales.
Here’s a breakdown of recent trading of $ESPR stock by insiders over the last 6 months:
- SHELDON L. KOENIG (President and CEO) has made 0 purchases and 3 sales selling 102,249 shares for an estimated $326,001.
- BENJAMIN LOOKER (Chief Legal Officer) has made 0 purchases and 5 sales selling 21,429 shares for an estimated $65,042.
- BENJAMIN HALLADAY (Chief Financial Officer) has made 0 purchases and 3 sales selling 20,807 shares for an estimated $64,066.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ESPR Hedge Fund Activity
We have seen 124 institutional investors add shares of $ESPR stock to their portfolio, and 78 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- D. E. SHAW & CO., INC. added 6,694,850 shares (+3208.9%) to their portfolio in Q4 2025, for an estimated $24,770,945
- ORBIMED ADVISORS LLC added 5,965,498 shares (+inf%) to their portfolio in Q4 2025, for an estimated $22,072,342
- EVERSEPT PARTNERS, LP added 3,851,133 shares (+inf%) to their portfolio in Q4 2025, for an estimated $14,249,192
- INDABA CAPITAL MANAGEMENT, L.P. removed 3,000,000 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $7,950,000
- MILLENNIUM MANAGEMENT LLC added 2,957,418 shares (+303.4%) to their portfolio in Q4 2025, for an estimated $10,942,446
- MARSHALL WACE, LLP added 2,950,172 shares (+117.0%) to their portfolio in Q4 2025, for an estimated $10,915,636
- VANGUARD GROUP INC added 2,853,005 shares (+23.6%) to their portfolio in Q4 2025, for an estimated $10,556,118
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$ESPR Analyst Ratings
Wall Street analysts have issued reports on $ESPR in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Piper Sandler issued a "Overweight" rating on 11/25/2025
To track analyst ratings and price targets for $ESPR, check out Quiver Quantitative's $ESPR forecast page.
$ESPR Price Targets
Multiple analysts have issued price targets for $ESPR recently. We have seen 3 analysts offer price targets for $ESPR in the last 6 months, with a median target of $5.0.
Here are some recent targets:
- Jason N. Butler from Citizens set a target price of $5.0 on 03/13/2026
- Serge Belanger from Needham set a target price of $5.0 on 03/03/2026
- David Amsellem from Piper Sandler set a target price of $9.0 on 11/25/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
